Dr. Bruce Seet is a leader and advocate for broadening professional development opportunities for highly qualified personnel (HQP) in STEM. Bruce founded and serves as the President/CEO of the Science to Business Network (www.s2bn.org), a national multi-chapter non-profit organization established in 2011 that connects stakeholders in industry, government and academia and provides professional development opportunities for HQP in Canada. As a Director, Medical Affairs at Sanofi Pasteur, he has been an advisor and mentor to more than a dozen pharmacy and HQP residents as part of the Leslie Dan School of Pharmacy Advanced Pharmacy Practice Experience, the University of Waterloo pharmacy co-op program and the Queen’s University’s Graduate Diploma in Pharmaceutical & Healthcare Management and Innovation. He also serves on the Research Management Committee as well as the HQP Development Committee for BioCanRx, an NCE that accelerates the development of cancer immunotherapeutics in Canada. Dr. Seet is an Adjunct Professor in the Department of Molecular Genetics at the University of Toronto where he teaches and supports graduate professional development in the department. Dr. Seet earned a B.Sc (Honours Physiology) and a Ph.D. (Microbiology and Immunology) from Western University, followed by a postdoctoral research fellowship at Mt. Sinai Hospital (Toronto). Bruce worked at GlaxoSmithKline (GSK) from 2006 to 2014 in a variety of roles. While at GSK, he completed his MBA at the Rotman School of Management (Toronto). In 2014, Bruce moved to Sanofi Pasteur where he continues to work as a Director, Medical Affairs.